FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

38162111000001100: Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Mar 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1248201000001112 Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1248221000001117 Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet Has AMP Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet Is a Lamivudine 300mg / Tenofovir disoproxil 245mg tablets 90 tablet true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tenofovir disoproxil true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet Has specific active ingredient Lamivudine true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet Has specific active ingredient Tenofovir disoproxil fumarate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start